Ocugen Statistics

Total Valuation

Ocugen has a market cap or net worth of MXN 6.93 billion. The enterprise value is 6.94 billion.

Market Cap	6.93B
Enterprise Value	6.94B

Important Dates

The next estimated earnings date is Monday, March 2, 2026.

Earnings Date	Mar 2, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	312.32M
Shares Outstanding	n/a
Shares Change (YoY)	+12.36%
Shares Change (QoQ)	+4.09%
Owned by Insiders (%)	1.49%
Owned by Institutions (%)	14.82%
Float	307.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	70.38
PB Ratio	106.98
P/TBV Ratio	106.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.91
EV / Sales	71.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.07

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 9.33.

Current Ratio	1.85
Quick Ratio	1.60
Debt / Equity	9.33
Debt / EBITDA	n/a
Debt / FCF	-0.62
Interest Coverage	-16.16

Financial Efficiency

Return on equity (ROE) is -289.93% and return on invested capital (ROIC) is -90.71%.

Return on Equity (ROE)	-289.93%
Return on Assets (ROA)	-63.67%
Return on Invested Capital (ROIC)	-90.71%
Return on Capital Employed (ROCE)	-163.53%
Revenue Per Employee	1.04M
Profits Per Employee	-12.36M
Employee Count	95
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.28% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+24.28%
50-Day Moving Average	25.47
200-Day Moving Average	22.34
Relative Strength Index (RSI)	42.70
Average Volume (20 Days)	421

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	11.91

Income Statement

In the last 12 months, Ocugen had revenue of MXN 98.50 million and -1.17 billion in losses. Loss per share was -3.98.

Revenue	98.50M
Gross Profit	-586.97M
Operating Income	-1.12B
Pretax Income	-1.17B
Net Income	-1.17B
EBITDA	-1.05B
EBIT	-1.12B
Loss Per Share	-3.98

Full Income Statement

Balance Sheet

The company has 597.31 million in cash and 604.63 million in debt, giving a net cash position of -7.32 million.

Cash & Cash Equivalents	597.31M
Total Debt	604.63M
Net Cash	-7.32M
Net Cash Per Share	n/a
Equity (Book Value)	64.80M
Book Value Per Share	0.21
Working Capital	316.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -978.87 million and capital expenditures -2.99 million, giving a free cash flow of -981.86 million.

Operating Cash Flow	-978.87M
Capital Expenditures	-2.99M
Free Cash Flow	-981.86M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,133.87%
Pretax Margin	-1,192.18%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ocugen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.36%
Shareholder Yield	-12.36%
Earnings Yield	-16.94%
FCF Yield	-14.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ocugen has an Altman Z-Score of -9.61 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.61
Piotroski F-Score	2